Anti Covid-19 Drug Molecule Developed By Hansraj College Researchers

Must read

#CelebratingPride : Section 377 and The Struggle Behind

As June is being celebrated as the pride month worldwide, there is no good a time to look back at the LGBTQ movement in...

DU Admissions 2020: Jesus and Mary College Opens Its Admission Portal

Besides admissions being open for aspirants into the University of Delhi, Jesus and Mary College, a college affiliated with the University of Delhi opened its...

Delhi University Appoints Its New Pro-Vice-Chancellor

University of Delhi: The University has appointed Professor PC Joshi as the new Pro-Vice-Chancellor of the University. He also serves as the Head of...
Anamika Ghai
I'm from Chandigarh, currently settled in Delhi, for my university. The pollution got the best of me, but I try.

As scientists of our entire world scurry to search for a vaccine against COVID-19, a team of researchers from Hansraj College, DU has claimed to have developed a potential anti-covid19 drug molecule.

The team led by Dr. Brijesh Rathi, an assistant professor in the Chemistry Department of Hansraj College, has extensively invested their time in in-silico experiments. After preclinical testing of the molecule against SARS-CoV-2 in India, Loyola University Chicago and University of New Mexico, Rathi along with his collaborators Dr. Steven Bradfute from University of New Mexico and Prof Ravi Durvasula and Dr. P Kempaiah from Loyola University have together filed the US provisional patent application: “Calxinin Compositions and method for treating Viral Infections.”

- Advertisement -

A UK based company named Radcliffe Bioscience has even agreed to conduct clinical trials on Calxinin. The company has assured that they’d try to develop an anti COVID drug as fast as they can with the help of this promising molecule. The company will be developing the drug molecule, beginning with toxicity testing and taking it to the animal efficacy level soon. The company has also mentioned in a letter that they’d be happy to collaborate with Dr. Rathi and his team in future endeavors.

While speaking to The Times of India, Dr. Rathi sounded hopeful about the emergence of an antiviral drug from the discovered molecule as he mentioned that they have almost completed pre-clinical trials and the rest is up to the company.

- Advertisement -

Download the DU Express android application today and stay updated with all the admission updates and college news 24×7 on your smartphone. Click here to download the app | IOS app launching soon.

DU Express is on Telegram (@DUExpressIndia). Subscribe to our channel by clicking here to stay updated with all the latest campus news, admission updates & college events happening near you for free!

- Advertisement -

- Advertisement -

Latest article

‘You’re escalating my anxiety’ – says a DU Student in an Instagram Video on OBE

Had everything gone well, Ima M R would have already completed her B.Sc degree from the University of Delhi. As she was set to...

Liverpool : The Premier League Winners and the Klopp Effect

For those who question the time take by football managers to yield successful results, Liverpool's triumph journey is evident enough that when...

For the ‘First Time in History’, Indian Railways Achieves 100% Punctuality

On 2nd July 2020, The Indian Railways announced that it achieved 100% punctuality of trains. It is the first time that this milestone has...